The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Open accessAbstract
Recently, much attention has been given to the problem of drug delivery through the cell-membrane in order to treat and manage several diseases. The discovery of cell penetrating peptides (CPPs) represents a major breakthrough for the transport of large-cargo molecules that may be useful in clinical applications. CPPs are rich in basic amino acids such as arginine and lysine and are able to translocate over membranes and gain access to the cell interior. They can deliver large-cargo molecules, such as oligonucleotides, into cells. Endocytosis and direct penetration have been suggested as the two major uptake mechanisms, a subject still under debate. Unresolved questions include the detailed molecular uptake mechanism(s), reasons for cell toxicity, and the delivery efficiency of CPPs for different cargoes. Here, we give a review focused on uptake mechanisms used by CPPs for membrane translocation and certain experimental factors that affect the mechanism(s).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,174
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
Self-citationWadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Cited by
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Cell-Penetrating Peptides: Design, Synthesis, and Applications
Copolovici, D. M., Langel, K., Eriste, E., & Langel, Ü. (2014) · ACS Nano · doi:10.1021/nn4057269 · Cited by 963
Self-citationCell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
A holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4503 · Cited by 480
Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Oller-Salvia, B., Sánchez-Navarro, M., Giralt, E., & Teixidó, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 442
Internalization mechanisms of cell-penetrating peptides
Ruseska, I., & Zimmer, A. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.10 · Cited by 436
Overcoming Endosomal Entrapment in Drug Delivery
Pei, D., & Buyanova, M. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00778 · Cited by 402
Jiang, Y., Huo, S., Mizuhara, T., Das, R., Lee, Y.-W., Hou, S., Moyano, D. F., Duncan, B., Liang, X.-J., & Rotello, V. M. (2015) · ACS Nano · doi:10.1021/acsnano.5b03521 · Cited by 401
Shan, W., Zhu, X., Liu, M., Li, L., Zhong, J., Sun, W., Zhang, Z., & Huang, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b00028 · Cited by 395
The therapeutic applications of antimicrobial peptides (AMPs): a patent review
Kang, H.-K., Kim, C., Seo, C. H., & Park, Y. (2017) · Journal of Microbiology · doi:10.1007/s12275-017-6452-1 · Cited by 386
Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T.-Y., & Pellois, J.-P. (2012) · Pharmaceuticals · doi:10.3390/ph5111177 · Cited by 384
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 379
Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
Wang, F., Wang, Y., Zhang, X., Zhang, W., Guo, S., & Jin, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.020 · Cited by 377
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
Cho, C.-F., Wolfe, J. M., Fadzen, C. M., Calligaris, D., Hornburg, K., Chiocca, E. A., Agar, N. Y. R., Pentelute, B. L., & Lawler, S. E. (2017) · Nature Communications · doi:10.1038/ncomms15623 · Cited by 336
Li, Y., He, D., Li, B., Lund, M. N., Xing, Y., Wang, Y., Li, F., Cao, X., Liu, Y., Chen, X., et al. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.009 · Cited by 321
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles
Salatin, S., & Yari Khosroushahi, A. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13110 · Cited by 315
Strategies for transporting nanoparticles across the blood–brain barrier
Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308
Promises and Pitfalls of Intracellular Delivery of Proteins
Fu, A., Tang, R., Hardie, J., Farkas, M. E., & Rotello, V. M. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500320j · Cited by 306
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Kim, B., Park, J., & Sailor, M. J. (2019) · Advanced Materials · doi:10.1002/adma.201903637 · Cited by 298
Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue
Lovatt, D., Ruble, B. K., Lee, J., Dueck, H., Kim, T. K., Fisher, S., Francis, C., Spaethling, J. M., Wolf, J. A., Grady, M. S., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2804 · Cited by 287
“TIVA-tag synthesis was done according to the structure outlined in Figure 1 on either 1 µmol or 10 µmol scales with the following reagents (Glen Research): 2′-deoxy-2′fluoro-uridine phosphoramidite (10-3430), 2′-O-methyladenosine phosphoramidite (10-3100), Cy3 phosphoramidite (10-5913), Cy5 phosphoramidite (10-5915),…”
Antimicrobial Peptides: Versatile Biological Properties
Pushpanathan, M., Gunasekaran, P., & Rajendhran, J. (2013) · International Journal of Peptides · doi:10.1155/2013/675391 · Cited by 292
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Dissanayake, S., Denny, W. A., Gamage, S., & Sarojini, V. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.006 · Cited by 280
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Habault, J., & Poyet, J.-L. (2019) · Molecules · doi:10.3390/molecules24050927 · Cited by 280
Shi, G., Monro, S., Hennigar, R., Colpitts, J., Fong, J., Kasimova, K., Yin, H., DeCoste, R., Spencer, C., Chamberlain, L., et al. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.04.012 · Cited by 279
Farkhani, S. M., Valizadeh, A., Karami, H., Mohammadi, S., Sohrabi, N., & Badrzadeh, F. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.015 · Cited by 273
Organelle targeting: third level of drug targeting
Padh, H., & Sakhrani, N. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s45614 · Cited by 269
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer
Bolhassani, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.006 · Cited by 257
McCarthy, H. O., McCaffrey, J., McCrudden, C. M., Zholobenko, A., Ali, A. A., McBride, J. W., Massey, A. S., Pentlavalli, S., Chen, K.-H., Cole, G., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.048 · Cited by 216
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181
Yao, Q., Dai, Z., Hoon Choi, J., Kim, D., & Zhu, L. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09511 · Cited by 71
Gene Delivery Technologies with Applications in Microalgal Genetic Engineering
Gutiérrez, S., & Lauersen, K. J. (2021) · Biology · doi:10.3390/biology10040265 · Cited by 68
Jiao, Y., Yang, L., Wang, R., Song, G., Fu, J., Wang, J., Gao, N., & Wang, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121611 · Cited by 63
Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity
Gronewold, A., Horn, M., Ranđelović, I., Tóvári, J., Muñoz Vázquez, S., Schomäcker, K., & Neundorf, I. (2017) · ChemMedChem · doi:10.1002/cmdc.201600498 · Cited by 50
Kim, H., Seo, E.-H., Lee, S.-H., & Kim, B.-J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122054 · Cited by 48
Argonaute 4 as an Effector Protein in RNA-Directed DNA Methylation in Human Cells
Chalertpet, K., Pin-on, P., Aporntewan, C., Patchsung, M., Ingrungruanglert, P., Israsena, N., & Mutirangura, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00645 · Cited by 43
Cell penetrating peptide: A potent delivery system in vaccine development
Hasannejad-Asl, B., Pooresmaeil, F., Takamoli, S., Dabiri, M., & Bolhassani, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1072685 · Cited by 40
Effects of HIV-1 gp120 and tat on endothelial cell sensescence and senescence-associated microRNAs
Hijmans, J. G., Stockleman, K., Reiakvam, W., Levy, M. V., Brewster, L. M., Bammert, T. D., Greiner, J. J., Connick, E., & DeSouza, C. A. (2018) · Physiological Reports · doi:10.14814/phy2.13647 · Cited by 31
Advances and prospects of cell-penetrating peptides in tumor immunotherapy
Yang, D., Liu, B., & Sha, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-86130-8 · Cited by 31
Mc Larney, B. E., Sonay, A. Y., Apfelbaum, E., Mostafa, N., Monette, S., Goerzen, D., Aguirre, N., Exner, R. M., Habjan, C., Isaac, E., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01248-w · Cited by 28
Al-azzawi, S., & Masheta, D. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-00424-w · Cited by 28
Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines
Wylie, B., Ong, F., Belhoul-Fakir, H., Priebatsch, K., Bogdawa, H., Stirnweiss, A., Watt, P., Cunningham, P., Stone, S. R., & Waithman, J. (2021) · Cancers · doi:10.3390/cancers13246189 · Cited by 16
Metadata
- Authors
- Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A.
- Venue
- Journal of Biophysics
- Publisher
- Hindawi Limited
- Published
- 2011-04-07
- Volume
- 2011
- Pages
- 1-10
- ISSN
- 1687-8000 (ISSN-L)
- 1687-8019
- OpenAlex
- W2052706007
- Cited by
- 984
- References
- 73
- FWCI
- 24.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.